• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Rare Diseases

    AI Boosts Jaguar Health`s Crofelemer for Rare Disease Therapy

    PHARMIWEB

    Jaguar Health Announces Abstract Submission for Preliminary Data

    PHARMIWEB

    Jaguar Health Strengthens Global IP With New Crofelemer Patent

    PHARMIWEB

    Jaguar Health Submits Amended Protocol To FDA For Crofelemer

    PHARMIWEB

    Jaguar Health Meets FDA To Advance Crofelemer Trial

    PHARMIWEB

    FDA Grants Expanded Access for Jaguar’s Crofelemer in MVID

    PHARMAWEB

    Jaguar Health Seeks FDA Orphan Drug Designation for Crofelemer

    PHARMAWEB

    Napo Pharma, FDA Discuss Crofelemer for Pediatric MVID Treatment

    PHARMAWEB

    Jaguar Health to Add Crypto to Treasury Reserves

    ACCESSWIRE

    Jaguar Health Extends Maturity Date of Convertible Notes to Jan

    ACCESSWIRE

    Jaguar Health Updates Orphan Disease Intestinal Failure Program

    ACCESSWIRE

    Jaguar Health Fireside Chat Set for June 10 at 9AM ET

    ACCESSWIRE

    Jaguar Health Updates FDA Meeting on Breast Cancer Trial Results

    ACCESSWIRE

    Jaguar Starts Phase 2 Trial of Crofelemer for Pediatric MVID

    ACCESSWIRE

    Crofelemer Shows Benefit in Rare Bowel Disorders

    ACCESSWIRE

    Jaguar to Share Crofelemer Study Data in April 30 Webcast

    ACCESSWIRE

    Jaguar Health to Present Initial Results from Crofelemer Study

    ACCESSWIRE

    Jaguar Health Doses 1st Patient In Evaluating Crofelemer For MVID

    YAHOOFINANCE

    FDA Approves Orphan-Drug Designation for Jaguar Health’s Crofelemer

    ACCESSWIRE

    Ladenburg Hosts Showcase On Jaguar`s Rare Disease Research

    ACCESSWIRE

    Jaguar Health`s Executive VP Dr. Karen Brunke Joins BIO`s Rare Disease Committee

    ACCESSWIRE

    FDA Grants Orphan Drug Designation to Jaguar Health for Crofelemer for MVID

    ACCESSWIRE

    Jaguar Provides Updates Regarding Company`s Focus on Rare and Orphan Disease

    ACCESSWIRE

    European Medicines Grants Orphan Drug Designation for Crofelemer for (MVID)

    ACCESSWIRE

    ODD Application Submitted by Jaguar Health Subsidiary for Crofelemer

    BIOSPACE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.